z-logo
open-access-imgOpen Access
Pre-column Derivatization and Separation of Diastereomeric-Derivatives of Racemic Mexiletine and Confirmation of Elution Order and Molecular Configuration
Author(s) -
Tousief Irshad Ahmed,
Vijay Alwera,
V.S. Talismanov,
Nagadeep Jaishetty,
Suman Sehlangia,
Shiv Alwera
Publication year - 2022
Publication title -
asian journal of chemistry/asian journal of chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 34
eISSN - 0975-427X
pISSN - 0970-7077
DOI - 10.14233/ajchem.2022.23706
Subject(s) - chemistry , mexiletine , diastereomer , cyanuric chloride , enantiomer , elution , chromatography , reagent , enantiomeric excess , derivatization , calibration curve , high performance liquid chromatography , organic chemistry , detection limit , enantioselective synthesis , catalysis , medicine , anesthesia
Present study describes the synthesis of cyanuric chloride based four active chiral reagents (ACRs)and their application in the enantiomeric separation of (RS)-mexiletine. Herein, four cyanuricchloride-based ACRs were prepared by introducing L-proline derivatives under nucleophilic substitutionreaction. The synthesized ACRs were characterized by different spectroscopic techniques. Racemicmexiletine hydrochloride was used for the enantio-recognition study. All the four ACRs were used toconvert (RS)-mexiletine into related diastereomeric derivatives and then separated on the C18-columnof RP-HPLC. The different parameters such as sample amount, the concentration of mobile phase,organic modifier and pump pressure were varied to optimize separation conditions. Theenergy-minimized structures of synthesized diasteromeric derivatives (DDs) were developed usingDFT calculations. The validation study was conducted for the developed method andcorrelation-coefficient, calibration range, LOD and LOQ calculated. The stability and recovery werecalculated by inter and intraday assay.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here